NCT06186843 is a NA clinical trial of Plant-based diet in Kidney Disease, Chronic, sponsored by George Washington University.

Who is sponsoring NCT06186843?

NCT06186843 is sponsored by George Washington University.

What drugs are being tested in NCT06186843?

Interventions in NCT06186843: Plant-based diet.

What condition does NCT06186843 study?

NCT06186843 studies Kidney Disease, Chronic, Transplant Complication, Hypertension, Diabetes Mellitus, Metabolic Syndrome, Inflammation, Kidney Transplant Failure, Dietary Habits.

Is NCT06186843 still recruiting?

NCT06186843 is currently active, enrolled. Last updated 5 September 2025.

Last reviewed 2025-09-05 · How we verify

NCT06186843

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Plant-based Diet for Kidney Transplant Recipients

Active, enrolled NA Last updated 5 September 2025

What this trial tests

NA trial testing Plant-based diet in Kidney Disease, Chronic in 25 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

29 February 2024

Primary endpoint
25 March 2026

1 June 2026

Quick facts

Lead sponsor	George Washington University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	25
Start date	29 February 2024
Primary completion	25 March 2026
Estimated completion	1 June 2026
Sites	1 location across United States

Drugs / interventions tested

Plant-based diet

Conditions studied

Kidney Disease, Chronic — all drugs for Kidney Disease, Chronic →
Transplant Complication — all drugs for Transplant Complication →
Hypertension — all drugs for Hypertension →
Diabetes Mellitus — all drugs for Diabetes Mellitus →

Sponsor

George Washington University

Who can join

Adults 18 to 80, any sex, with Kidney Disease, Chronic or Transplant Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate cardiometabolic and inflammatory parameters in kidney transplant recipients after transitioning to a plant-based diet (PBD). The main aims of the study are as follows: * To test the feasibility of transiting renal allograft recipients who are \> 3 months post-transplant to a PBD * To study the effect of a PBD on cardiometabolic parameters in kidney transplant recipients * To assess the effect of a PBD on peripheral blood Th17/Treg ratio and systemic inflammation in kidney transplant recipients Participants will be asked to: * Complete a 2-week investigator-designed PBD transition program * Follow a PBD for a minimum of 16 weeks * Consent for blood draws, urine samples, and fecal samples along with physical exams * Complete intermittent food frequency questionnaires and quality of life questionnaires * Periodically meet with investigators and other study participants Researchers will compare baseline measurements with future measurements for each participant.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Plant-based diet

Trials testing the same drug.

NCT06571279 — Assessing the Impact of a Plant-Based Diet for Diabetes Prevention · NA · completed
NCT05885828 — The PRECISION-T2D Study: Precision Nutrition Study for Type 2 Diabetes · NA · recruiting
NCT05659966 — Nutritious Eating With Soul Dissemination and Implementation · NA · active not recruiting
NCT05706649 — A Study of Plant-based Diet on Postprandial Sleepiness · NA · completed
NCT05231317 — Effect of the Sustainable Diet on Gut Microbiota and the Metabolome: a Randomised Crossover Study · NA · completed

Other recruiting trials for Kidney Disease, Chronic

Currently open trials in the same condition.

NCT07217535 — Rutgers University Study of the Genetics of Kidney Disease · recruiting
NCT06343727 — A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF) · NA · recruiting
NCT06701825 — Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus · Phase 4 · recruiting
NCT06830473 — KTRSensor Scotland Study: An Observational Study Into Predictors and Diagnosis of Kidney Transplant Rejection · recruiting
NCT06863194 — Probiotic Supplementation and Disease Progression in CKD: A Randomized Trial · Phase 1, PHASE2 · recruiting

Other George Washington University trials

Trials by the same sponsor.

NCT07279129 — Decision Support Tool to Integrate PrEP Into Emergency Departments · Phase 1 · not yet recruiting
NCT07524309 — Self-Help Plus Pilot Study, Colombia: Train2Care · NA · not yet recruiting
NCT07249008 — NSS Grocery Store Brazil · NA · recruiting
NCT07000513 — HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST L · Phase 4 · not yet recruiting
NCT07079306 — ChatGPT-Supported Text Messaging Program for Smoking Cessation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06186843 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by George Washington University
Last refreshed: 5 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06186843.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing